236 related articles for article (PubMed ID: 18061070)
21. Aldehyde dehydrogenase 2 protects human umbilical vein endothelial cells against oxidative damage and increases endothelial nitric oxide production to reverse nitroglycerin tolerance.
Hu XY; Fang Q; Ma D; Jiang L; Yang Y; Sun J; Yang C; Wang JS
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323160
[TBL] [Abstract][Full Text] [Related]
22. Monitoring white blood cell mitochondrial aldehyde dehydrogenase activity: implications for nitrate therapy in humans.
Wenzel P; Schulz E; Gori T; Ostad MA; Mäthner F; Schildknecht S; Göbel S; Oelze M; Stalleicken D; Warnholtz A; Münzel T; Daiber A
J Pharmacol Exp Ther; 2009 Jul; 330(1):63-71. PubMed ID: 19346443
[TBL] [Abstract][Full Text] [Related]
23. Bioactivation of nitroglycerin by the mitochondrial aldehyde dehydrogenase.
Chen Z; Stamler JS
Trends Cardiovasc Med; 2006 Nov; 16(8):259-65. PubMed ID: 17055381
[TBL] [Abstract][Full Text] [Related]
24. The role of lipoic acid in prevention of nitroglycerin tolerance.
Dudek M; Bednarski M; Bilska A; Iciek M; Sokołowska-Jezewicz M; Filipek B; Włodek L
Eur J Pharmacol; 2008 Sep; 591(1-3):203-10. PubMed ID: 18616939
[TBL] [Abstract][Full Text] [Related]
25. Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance.
Andrews KL; Lumsden NG; Farry J; Jefferis AM; Kemp-Harper BK; Chin-Dusting JP
Clin Sci (Lond); 2015 Jul; 129(2):179-87. PubMed ID: 25728899
[TBL] [Abstract][Full Text] [Related]
26. Partially irreversible inactivation of mitochondrial aldehyde dehydrogenase by nitroglycerin.
Beretta M; Sottler A; Schmidt K; Mayer B; Gorren AC
J Biol Chem; 2008 Nov; 283(45):30735-44. PubMed ID: 18786921
[TBL] [Abstract][Full Text] [Related]
27. Is the mechanism of nitroglycerin tolerance associated with aldehyde dehydrogenase activity? A contribution to the ongoing discussion.
Bilska-Wilkosz A; Kotańska M; Górny M; Filipek B; Iciek M
Acta Biochim Pol; 2019 Dec; 66(4):627-632. PubMed ID: 31883320
[TBL] [Abstract][Full Text] [Related]
28. Nitroglycerin use in myocardial infarction patients.
Ferreira JC; Mochly-Rosen D
Circ J; 2012; 76(1):15-21. PubMed ID: 22040938
[TBL] [Abstract][Full Text] [Related]
29. Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2-/- mice.
Wenzel P; Hink U; Oelze M; Seeling A; Isse T; Bruns K; Steinhoff L; Brandt M; Kleschyov AL; Schulz E; Lange K; Weiner H; Lehmann J; Lackner KJ; Kawamoto T; Münzel T; Daiber A
Br J Pharmacol; 2007 Feb; 150(4):526-33. PubMed ID: 17220910
[TBL] [Abstract][Full Text] [Related]
30. The nitric oxide donor RuBPY does not induce in vitro cross-tolerance with acetylcholine.
Paulo M; Grando MD; da Silva RS; Minshall RD; Bendhack LM
Nitric Oxide; 2017 Sep; 69():69-77. PubMed ID: 28559108
[TBL] [Abstract][Full Text] [Related]
31. The effect of vitamin C on nitroglycerin-mediated vasodilation in individuals with and without the aldehyde dehydrogenase 2 polymorphism.
He JD; Parker JD
Br J Clin Pharmacol; 2023 Sep; 89(9):2767-2774. PubMed ID: 37101414
[TBL] [Abstract][Full Text] [Related]
32. Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation.
Szöcs K; Lassègue B; Wenzel P; Wendt M; Daiber A; Oelze M; Meinertz T; Münzel T; Baldus S
J Mol Cell Cardiol; 2007 Jun; 42(6):1111-8. PubMed ID: 17493633
[TBL] [Abstract][Full Text] [Related]
33. Tolerance to nitroglycerin-induced preconditioning of the endothelium: a human in vivo study.
Gori T; Dragoni S; Di Stolfo G; Sicuro S; Liuni A; Luca MC; Thomas G; Oelze M; Daiber A; Parker JD
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H340-5. PubMed ID: 19933412
[TBL] [Abstract][Full Text] [Related]
34. Nitrate tolerance as a model of vascular dysfunction: roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress.
Daiber A; Oelze M; Wenzel P; Wickramanayake JM; Schuhmacher S; Jansen T; Lackner KJ; Torzewski M; Münzel T
Pharmacol Rep; 2009; 61(1):33-48. PubMed ID: 19307691
[TBL] [Abstract][Full Text] [Related]
35. Aldehyde dehydrogenase-independent bioactivation of nitroglycerin in porcine and bovine blood vessels.
Neubauer R; Wölkart G; Opelt M; Schwarzenegger C; Hofinger M; Neubauer A; Kollau A; Schmidt K; Schrammel A; Mayer B
Biochem Pharmacol; 2015 Feb; 93(4):440-8. PubMed ID: 25576686
[TBL] [Abstract][Full Text] [Related]
36. Decrease in endogenous CGRP release in nitroglycerin tolerance: role of ALDH-2.
Chen YR; Nie SD; Shan W; Jiang DJ; Shi RZ; Zhou Z; Guo R; Zhang Z; Li YJ
Eur J Pharmacol; 2007 Sep; 571(1):44-50. PubMed ID: 17585900
[TBL] [Abstract][Full Text] [Related]
37. Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure.
Daiber A; Oelze M; Coldewey M; Kaiser K; Huth C; Schildknecht S; Bachschmid M; Nazirisadeh Y; Ullrich V; Mülsch A; Münzel T; Tsilimingas N
Biochem Biophys Res Commun; 2005 Dec; 338(4):1865-74. PubMed ID: 16289107
[TBL] [Abstract][Full Text] [Related]
38. ALDH-2 deficiency increases cardiovascular oxidative stress--evidence for indirect antioxidative properties.
Wenzel P; Müller J; Zurmeyer S; Schuhmacher S; Schulz E; Oelze M; Pautz A; Kawamoto T; Wojnowski L; Kleinert H; Münzel T; Daiber A
Biochem Biophys Res Commun; 2008 Feb; 367(1):137-43. PubMed ID: 18157936
[TBL] [Abstract][Full Text] [Related]
39. Tolerance development and arterial and venous tissue-/plasma levels of glyceryl trinitrate and glyceryl dinitrate in patients treated with nitroglycerin infusion.
Torfgård KE; Svedjeholm R; Håkansson E; Ahlner J
Arzneimittelforschung; 1995 Sep; 45(9):963-6. PubMed ID: 7488313
[TBL] [Abstract][Full Text] [Related]
40. [Recent findings on nitrates: their action, bioactivation and development of tolerance].
Münzel T
Dtsch Med Wochenschr; 2008 Oct; 133(44):2277-82. PubMed ID: 18946854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
